Therefore, NT-proBNP helps identify hypertensive patients with T2DM at risk of cardiac damage, even subclinical, with an indication to perform an echocardiogram and refer to a specialist team, allowing the early implementation of effective strategies to prevent or delay the progression to overt and advanced stages of the cardiac disease. This evidence concerns the gene NPPB and heart disorder.